Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
US7214673B2 · kind B2 · utility
8Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 17, 2003 |
| Grant date | May 8, 2007 |
| Priority date | — |
| Expiry date | Mar 16, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Described herein are antipyschotic compounds of formula (I)wherein,
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.